QR Kodea

Efficacy of Everolimus Low-Dose Treatment for Cardiac Rhabdomyomas in Neonatal Tuberous Sclerosis: Case Report and Literature Review

<i>Background</i>: Cardiac rhabdomyomas (CRs) are the most common cardiac tumors in newborns. Approximately 80–90% of cases are associated with tuberous sclerosis complex (TSC). In selective cases, Everolimus has resulted in a remarkable tumoral regression effect in children with TS. The optimal dos...

Deskribapen osoa

Gorde:
Egile Nagusiak: Luisa Federica Nespoli, Elena Albani, Carla Corti, Luigina Spaccini, Enrico Alfei, Irene Daniele, Gian Vincenzo Zuccotti, Gianluca Lista, Valeria Calcaterra, Savina Mannarino
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: MDPI AG 2021-03-01
Saila:Pediatric Reports
Gaiak:
cardiac rhabdomyoma
tuberous sclerosis
everolimus
neonate
low dose
Sarrera elektronikoa:https://www.mdpi.com/2036-7503/13/1/15
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak